Solid Bio Plunges on Mounting Gene Therapy Safety Issues

(Bloomberg) -- Shares of Solid Biosciences Inc fell as much as 41% Tuesday to a record low after the company reported serious side effects for a patient receiving its gene therapy treatment, SGT-00...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.